Estradiol protects hair cells from cisplatin-induced ototoxicity via Nrf2 activation

被引:6
作者
Adachi, Masahiro [1 ,2 ]
Yanagizono, Kota [1 ,2 ]
Okano, Yasuhito [1 ,2 ]
Koizumi, Hitoshi [1 ,2 ]
Uemaetomari, Isao [1 ]
Tabuchi, Keiji [1 ]
机构
[1] Univ Tsukuba, Dept Otolaryngol Head & Neck Surg, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan
[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Otolaryngol, Tsukuba, Japan
关键词
Cisplatin; cochlea hair cell; estradiol; GSTA4; Nrf2; organ of corti; ototoxicity; reactive oxygen species; INHIBITOR; ORGAN;
D O I
10.1080/13510002.2022.2161224
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cisplatin-induced ototoxicity is caused by reactive oxygen species. It has been recognized that estradiol (E2) regulates redox balance. However, little is known about the protective mechanisms of E2 against cisplatin-induced ototoxicity. In this study, we investigated the effect of E2 on nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated hair cell protection using the organ of Corti isolated from mice. The organ of Corti collected from C57BL/6 mice at 3-5 postnatal days was used in all experiments. The organ of Corti was exposed to 20 mu M cisplatin with/without 100 nM E2 to examine the effect of E2 on cisplatin-induced hair cell loss. The mRNA expression of Nrf2 and the phase II detoxification gene after E2 and cisplatin treatment was analyzed using quantitative real-time PCR. E2 significantly reduces cisplatin-induced cochlear hair cell death. In addition, 100 nM E2 increased the mRNA expression of Nrf2 and phase II detoxification genes in the organ of Corti under cisplatin treatment. Our results suggest that E2 activates Nrf2, phase II detoxification enzymes and exerts a protective effect against cisplatin-induced ototoxicity.
引用
收藏
页数:5
相关论文
共 25 条
  • [1] Cisplatin is retained in the cochlea indefinitely following chemotherapy
    Breglio, Andrew M.
    Rusheen, Aaron E.
    Shide, Eric D.
    Fernandez, Katharine A.
    Spielbauer, Katie K.
    McLachlin, Katherine M.
    Hall, Matthew D.
    Amable, Lauren
    Cunningham, Lisa L.
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [2] Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
    Brock, P. R.
    Maibach, R.
    Childs, M.
    Rajput, K.
    Roebuck, D.
    Sullivan, M. J.
    Laithier, V.
    Ronghe, M.
    Dall'Igna, P.
    Hiyama, E.
    Brichard, B.
    Skeen, J.
    Mateos, M. E.
    Capra, M.
    Rangaswami, A. A.
    Ansari, M.
    Rechnitzer, C.
    Veal, G. J.
    Covezzoli, A.
    Brugieres, L.
    Perilongo, G.
    Czauderna, P.
    Morland, B.
    Neuwelt, E. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25) : 2376 - 2385
  • [3] Auditory function and dysfunction: estrogen makes a difference
    Delhez, Amandine
    Lefebvre, Philippe
    Pequeux, Christel
    Malgrange, Brigitte
    Delacroix, Laurence
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (04) : 619 - 635
  • [4] Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes
    Hall, Matthew D.
    Telma, Katherine A.
    Chang, Ki-Eun
    Lee, Tobie D.
    Madigan, James P.
    Lloyd, John R.
    Goldlust, Ian S.
    Hoeschele, James D.
    Gottesman, Michael M.
    [J]. CANCER RESEARCH, 2014, 74 (14) : 3913 - 3922
  • [5] Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone
    Hellgren, M.
    Conrad, J.
    Norris, L.
    Kluft, C.
    [J]. MATURITAS, 2009, 62 (03) : 287 - 293
  • [6] Protective role of Nrf2 in age-related hearing loss and gentamicin ototoxicity
    Hoshino, Tomofumi
    Tabuchi, Keiji
    Nishimura, Bungo
    Tanaka, Shuho
    Nakayama, Masahiro
    Ishii, Tetsuro
    Warabi, Eiji
    Yanagawa, Toru
    Shimizu, Ritsuku
    Yamamoto, Masayuki
    Hara, Akira
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 415 (01) : 94 - 98
  • [7] Effects of cisplatin on the auditory function of ovariectomized rats with estrogen deficiency
    Hu, Xu-Jun
    Li, Fang-Fang
    Wang, Ying
    Lau, Chi-Chuen
    [J]. ACTA OTO-LARYNGOLOGICA, 2017, 137 (06) : 606 - 610
  • [8] Mechanism of Rapid Nuclear Factor-E2-Related Factor 2 (Nrf2) Activation via Membrane-Associated Estrogen Receptors: Roles of NADPH Oxidase 1, Neutral Sphingomyelinase 2 and Epidermal Growth Factor Receptor (EGFR)
    Ishii, Tetsuro
    Warabi, Eiji
    [J]. ANTIOXIDANTS, 2019, 8 (03)
  • [9] The protective role of ferulic acid against cisplatin-induced ototoxicity
    Jo, Eu-Ri
    Youn, Cha Kyung
    Jun, Yonghyun
    Cho, Sung Il
    [J]. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2019, 120 : 30 - 35
  • [10] Investigation of the freely available easy-to-use software 'EZR' for medical statistics
    Kanda, Y.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 (03) : 452 - 458